(Q81527959)

English

Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorub

scientific article published on 01 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

Hans Erik Johnsen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Ulf-Henrik Mellqvist

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Stig Lenhoff

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Martin Hjorth

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Gunnar Juliusson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jon Magnus Tangen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jan Westin

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Nordic Myeloma Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

112

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

129-135

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Guidelines on the diagnosis and management of multiple myeloma 2005.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

VAD-based regimens as primary treatment for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma treated with high dose intravenous melphalan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

VAD chemotherapy as remission induction for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Single agent vincristine by infusion in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Do anthracyclines have a role in the therapy of multiple myeloma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

HPV16 DNA and prediction of high-grade CIN

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly cyclophosphamide and alternate-day prednisone: an effective, convenient, and well-tolerated oral treatment for relapsed multiple myeloma after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23145

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23145

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17973267%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81527959&oldid=1764278283"